Skip to main content

Hematology/Oncology and Stem Cell Therapy

  • Volume Issue

  • ISSN: 1658-3876

Editor-In-Chief: Mahmoud Aljurf

As of 2022 the journal has been transferred to the society. Visit the new homepage at Hemat… Read more

Subscription options

Institutional subscription on ScienceDirect

Request a sales quote

As of 2022 the journal has been transferred to the society. Visit the new homepage at Hematology/Oncology and Stem Cell Therapy King Faisal Specialist Hospital & Research Center hosct.org.

Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors. The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles and special communications. It also offers a special section for clinically relevant images that provide an important educational value.